An External Ventricular Drain (EVD) is a medical device that drains excess cerebrospinal fluid (CSF) from the brain's ventricles, relieving pressure caused by illnesses such as hydrocephalus, traumatic brain injury, or other neurovascular problems. The EVD is usually introduced through a catheter placed in one of the brain's ventricles, with the other end attached to an external drainage system. This treatment is routinely used in intensive care units, particularly for patients with excessive intracranial pressure. An EVD prevents issues like brain injury by continually draining excess CSF, and it can also monitor intracranial pressure in real time. The device is crucial in stabilizing patients until additional therapy, such as surgery or shunt insertion, can be scheduled.
Market Drivers: Government programs are being developed in many countries, including awareness campaigns to prevent and control traumatic brain injuries and the distribution of grants and investments to find viable treatments to improve recovery from brain injuries. The health department of the Australian government, for instance, has made large investments to improve treatment for those who have suffered severe injuries. Important market participants are being urged by these government initiatives to participate in the external ventricular drain market and conduct additional research on the disease. Therefore, it is anticipated that these factors will propel expansion in the external ventricular drain market's traumatic brain injury sector.
Challenges: There are a number of obstacles that could prevent the External Ventricular Drain (EVD) industry from growing. Given that EVD insertion and maintenance necessitate rigorous aseptic protocols, one significant concern is the possibility of infection. Infections within the ventricular system or at the point of insertion can cause meningitis or ventriculitis, among other severe consequences. Ineffective drainage and worsening of the patient's health might result from mechanical failure of the drain, such as obstructions or catheter dislodgement. The potential for long-term usage, frequent monitoring, and care requirements can further raise healthcare expenses and strain medical personnel.
By Region: In 2022, North America held the largest revenue share and led the external ventricular drain market. The region's high frequency of neurovascular disorders and higher incidence of traumatic brain injuries may be the cause of this dominance. A considerable number of deaths occur from stroke each year, making it one of the leading causes of death, according to the Centers for Disease Control and Prevention.
Global External Ventricular Drain (EVD) Market Key Players:
B. Braun SE, Fuji Systems, Integra LifeSciences, Medtronic, Möller Medical GmbH, Neuromedex GmbH, Sophysa, Spiegelberg GmbH & Co. KG, Others.
Global External Ventricular Drain (EVD) Market Segmentation:
By Application: Based on the Application, Global External Ventricular Drain (EVD) Market is segmented as; Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Other Non-traumatic Hydrocephalus Conditions.
By Patient Type: Based on the Patient Type, Global External Ventricular Drain (EVD) Market is segmented as; Pediatric, Adult.
By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.